Description

Tenecteplase (TNK-tPA) is a modified tissue plasminogen activator. Tenecteplase (TNK-tPA) can be used for acute ischaemic stroke diseases research[1].–80°C-Applications-Metabolism-protein/nucleotide metabolism-Formula-N/A-Citation–References-[1]Kvistad CE, et al. Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial. Lancet Neurol. 2022 Jun;21(6):511-519.-CASNumber-191588-94-0-MolecularWeight-N/A-Compound Purity-95.0-SMILES-[Tenecteplase]-Research_Area-Metabolic Disease-Solubility-10 mM in DMSO-Target-Others-Isoform–Pathway-Others-MCE Product type-Enzyme